BIO-FD&C Co.,Ltd. (KOSDAQ:251120)
South Korea · Delayed Price · Currency is KRW 14,210
+60 (0.42%)
At close: Apr 23, 2026
BIO-FD&C Market Cap
BIO-FD&C has a market cap or net worth of 125.65 billion as of April 24, 2026. Its market cap has increased by 11.15% in one year.
Market Cap
125.65B
Enterprise Value
73.25B
Revenue
19.18B
Ranking
n/a
PE Ratio
18.50
Stock Price
14,210.00
Market Cap Chart
Since February 21, 2022, BIO-FD&C's market cap has decreased from 193.04B to 125.65B, a decrease of -34.91%. That is a compound annual growth rate of -9.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2026 | 125.65B | -8.54% |
| Dec 30, 2025 | 137.39B | 14.33% |
| Dec 30, 2024 | 120.17B | -2.12% |
| Dec 28, 2023 | 122.78B | -16.94% |
| Dec 29, 2022 | 147.83B | -23.42% |
| Feb 21, 2022 | 193.04B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| QuadMedicine | 149.50B |
| CORESTEMCHEMON | 144.17B |
| NovMetaPharma | 120.58B |
| Cell Biotech | 110.12B |
| TegoScience | 102.80B |
| KoBioLabs | 102.73B |
| CHA Vaccine Research Institute | 96.98B |
| Quratis | 95.42B |